Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

BIS Targets Chinese Companies with Entity List Additions

By Tim Laderach on May 15, 2024
Email this postTweet this postLike this postShare this post on LinkedIn

On Thursday, May 9, 2024, the U.S. Department of Commerce Bureau of Industry and Security (BIS) added 37 Chinese entities to the Entity List. Among them were technology companies (predominately those tied to quantum computing), manufacturing firms, and research institutions. No person may export, reexport, or transfer any items subject to the Export Administrative Regulation (EAR) to these persons without a license.   BIS will review any license requests from these entities with a presumption of denial.

BIS designated these parties because they: (i) shipped U.S. controlled items to Russia, (ii) attempted to acquire controlled items to aid China’s military or quantum technologies capabilities, or (iii) had ties to, or were involved with, China’s “High Altitude Balloon” that overflew the United States in February 2023. These additions are part of the U.S.’s broad strategy to impede both China’s access to critical and emerging technologies (CET) and deter support for Russia’s invasion of Ukraine. Last week the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC) issued new sanctions on Chinese (and other) entities supporting Russia’s invasion of Ukraine.

If you have any questions about the recent additions to the BIS Entity List, contact Crowell’s International Trade Team.

Photo of Tim Laderach Tim Laderach

Tim Laderach is an associate in Crowell & Moring’s Antitrust and International Trade practices. He creatively leverages his extensive military and healthcare background to help clients meet their business and legal objectives. His practice spans transactions, investigations, compliance, and regulatory advice.

Tim also

…

Tim Laderach is an associate in Crowell & Moring’s Antitrust and International Trade practices. He creatively leverages his extensive military and healthcare background to help clients meet their business and legal objectives. His practice spans transactions, investigations, compliance, and regulatory advice.

Tim also maintains an active pro bono practice representing clients seeking political asylum.

While in law school, Tim was a law clerk on Capitol Hill with the majority staff of the Senate Judiciary Committee. There, he authored a memo on competition issues with artificial intelligence (AI)-based pricing algorithms. He was also engaged in a wide variety of the committee’s portfolio, including agency oversight, hearing preparation, and legislative research for national security-related bills pending before the committee. Additionally, Tim has experience as an intern at the Federal Trade Commission (FTC) Healthcare Division. He was involved with a variety of conduct litigation and conducted initial research on Pharmacy Benefit Managers ahead of the current 6-B study.

Tim served on active duty in the U.S. Navy prior to law school. He completed tours as outpatient pharmacy division officer at Naval Hospital Jacksonville Florida and later as pharmacy department head at the Office of Attending Physician, U.S. Capitol. He continues his service now as an officer in the U.S. Navy Reserve.

Read more about Tim LaderachEmailTim's Linkedin Profile
Show more Show less
  • Posted in:
    Administrative and Regulatory
  • Blog:
    International Trade Law
  • Organization:
    Crowell & Moring LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo